| Literature DB >> 34776462 |
Takahiro Miyahara1,2, Gohsuke Hattori1, Hisaaki Uchikado1,3, Yasuyuki Kaku4, Yuki Ohmori4, Kimihiko Orito1, Yasuharu Takeuchi1, Takayuki Kawano1,4, Masaru Hirohata1, Akitake Mukasa4, Motohiro Morioka1.
Abstract
Spinal arteriovenous (AV) shunts are rare conditions that sometimes present with myelopathy symptoms. The progression of the symptoms is usually gradual; however, some cases show rapid deterioration. We retrospectively investigated the factors that induced the rapid deterioration of myelopathy symptoms in patients with spinal AV shunts. We treated 33 patients with myelopathy with spinal AV shunts at our institutions, eight of whom experienced rapid deterioration (within 24 hours: 24.2%). Of these, three were related to the body movement or particular postures associated with playing golf, 30 minutes of Japanese straight sitting, and massage care. One patient showed deterioration after embolization for a tracheal aneurysm. The remaining four patients received steroid pulse therapy (high-dose steroid infusion) shortly before the rapid deterioration. These symptoms stopped progressing after cessation of steroid use. While positional or physical factors contributing to myelopathy deterioration might exist, we could not identify specific factors in this study. Nevertheless, rapid deterioration was frequently observed after high-dose steroid use. We must take care not to administer high-dose steroids for myelopathy caused by spinal AV shunt disease.Entities:
Keywords: myelopathy; spinal arteriovenous shunts; steroid
Mesh:
Year: 2021 PMID: 34776462 PMCID: PMC8841232 DOI: 10.2176/nmc.oa.2020-0439
Source DB: PubMed Journal: Neurol Med Chir (Tokyo) ISSN: 0470-8105 Impact factor: 1.742
Clinical data of the 33 patients with myelopathy caused by spinal AVF disease
| Sex (F:M) | 5:28 (male: 84.8%) |
| Age (mean) | 65.9 years (43–84 years) |
| Time to diagnosis (mean) | 19.5 months (4 days–10 years) |
| Location of AV shunt | |
| Craniocervical junction | 4 (11.4%) |
| Cervical | 1 (2.8%) |
| Thoracic | 18 (51.4%) |
| Lumbar | 10 (28.5%) |
| Sacral | 2 (5.7%) |
| Symptoms | |
| Weakness | 31 (93.9%) |
| Gait disturbance | 30 (90.0%) |
| Sensory disturbance | 27 (81.8%) |
| Urinary sphincter dysfunction | 17 (51.5%) |
| Deterioration pattern | |
| 1) Rapid (<24 h), n = 8 | |
| Ordinary activity | 3 |
| Golf | (1) |
| Japanese sitting 30 min | (1) |
| Massage care | (1) |
| Medical procedure | 5 |
| Other lesion embolization | (1) |
| Steroid pulse | (4) |
| 2) Subacute (1–3 days), n = 4 | |
| Ordinary activity | 1 |
| Climbing up stairs | (1) |
| Medical procedure | 3 |
| Steroid (low dose) | (1) |
| PGE1 agent | (2) |
AVF: arteriovenous fistula, F: female, M: male, AV: arteriovenous, PGE1: prostaglandin E1.
Summary of four cases deteriorated during ordinary daily activities
| Sex | Age (years) | Level | Symptoms | Induced activities | Deteriorating course |
|---|---|---|---|---|---|
| M | 61 | Th7 | L/E weakness and sensory impairment, gait disturbance, urinary sphincter dysfunction | Golf | Rapid |
| M | 74 | L4 | L/E weakness, gait disturbance | Massage | Rapid |
| M | 75 | Th6 | L/E weakness and sensory impairment, gait disturbance | Sitting | Rapid |
| F | 43 | Th7, Th8, Th9, Th12, L3 | L/E weakness, urinary sphincter deterioration | Climbing stairs | Subacute |
M: male, F: female, L/E: lower extremity.
Lower extremity MMT and other symptoms before and after the event of rapidly deteriorated patients
| Before | After | |||
|---|---|---|---|---|
| L/E MMT | Others | L/E MMT | Others | |
| 1 (Steroid) | 4 | S, P | 3 | S, P |
| 2 (Tracheal aneurysm embolization) | 4 | 3 | U | |
| 3 (Steroid) | 3 | S, U | 0–1 | S, U |
| 4 (Steroid) | 4–5 | 3 | U | |
| 5 (Steroid) | 4 | S, U | 0–1 | S, U |
| 6 (Sitting) | 4–5 | S | 3 | S |
| 7 (Golf) | 5 | S | 4 | S, U |
| 8 (Massage) | 4–5 | 3 | ||
MMT: manual muscle test, L/E: lower extremity, S: sensory disturbance, P: pain, U: urinary impairment.
Fig. 1(Case 1 in Table 4) (A) MRI T2WI revealing high-intensity lesion at the medulla and cervical cord. (B and C) CT angiography and digital subtraction angiography revealing dural AVF at the craniocervical junction. 72-year-old man: The patient had laminoplasty before cervical OPLL; 8 years later, R/E extremity weakness and urinary retention occurred. The symptoms gradually worsened despite having received physical therapy at another hospital. MRI revealed hyperintensity at the medulla and cervical cord. SDAVF was suspected, and the patient was referred to our service. The symptoms rapidly worsened after administration of steroids (hemiparesis MMT 3 ⇒ tetraparesis MMT 1). Emergent angiography revealed SDAVF at the cervico-medullary junction. The patient’s symptoms gradually resolved after surgical treatment and physical therapy. AVF: arteriovenous fistula, CT: computed tomography, MMT: manual muscle test, MRI: magnetic resonance imaging, OPLL: ossification of posterior longitudinal ligament, SDAVF: spinal dural arteriovenous fistula, T2WI: T2-weighted image.
Fig. 2(Case 3 in Table 4) (A and B) T2WI of MRI at first admission at the thoracic region. (C) Emergent MRI of T2WI after rapid deterioration following steroid pulse treatment. (D) Angiography revealing a perimedullary AVF. 45-year-old woman: The patient complained of motor weakness, pain, dysesthesia, and hyperreflexia in both lower extremities and gait disturbance, and MR T2WI showed intramedullary high intensity at Th 8 and 9 (A and B). In the first hospital, she was suspected of having multiple sclerosis and was administered methylprednisolone (1000 mg/day for 3 days); however, her motor and sensory disturbance worsened (MMT 4 to 3) the same day. Emergent reexamination of MRI was performed, and spinal AVF disease was suspected based on the findings of the small vessels around the spinal cord (C). The patient was referred to our hospital and surgery was performed. AVF: arteriovenous fistula, MMT: manual muscle test, MR: magnetic resonance, MRI: magnetic resonance imaging, T2WI: T2-weighted image.
Summary of previously reported cases and our cases showing rapid deterioration after steroid pulse treatment
| No. | Age (years)/sex | Level | Symptoms | Steroids | Symptoms after steroid use | Treatments | Postop. course |
|---|---|---|---|---|---|---|---|
| Söderlund27) | 63/M | Intracranial | Myelopathy including lower extremities | Methylprednisolone | Worsened, bilateral paraparesis | Steroid discontinuation | Recovery |
| Cabrera24) | 62/M | L2 | Lower extremities weakness and sensory disturbance, dysuria, constipation | Methylprednisolone | Worsened, bilateral paraparesis, pain | Steroid discontinuation | ? |
| McKeon26) | 52/M | Intracranial | Bilateral paraparesis, urinary retension | Prednisone/methylprednisolone | Worsened, flaccid paraplegia, urinary retension | Steroid discontinuation, surgical obliteration | Improved |
| McKeon26) | 51/F | L3 | Slowly progressive myelopathy | Methylprednisolone | Worsened, bilateral paraparesis | Steroid discontinuation, disconnection | Recovery, nonradiographic only |
| Mckeon26) | 58/F | L2 | Progressive lower extremities weakness and sensory disturbance | Methylprednisolone | Worsened rapidly, bilateral paraparesis | Steroid discontinuation, surgical treatment | Recovery |
| Strowd23) | 45/M | L3 | Allergic reaction, no neurological deficit | Prednisone/methylprednisolone | Worsened rapidly, bilateral paraparesis, urinary retension, sexual dysfunction | Steroid discontinuation, surgical treatment | Recovery |
| Disano28) | 63/F | L2 | Lower extremity sensory disturbance and clonus, urinary retention | Methylprednisolone | Worsened rapidly, paraparesis, sensory disturbance | Steroid discontinuation, surgical treatment | Mild improvement |
| Case | 72/M | Craniocervical junction | Rt. U/E weakness, urinary retension | Betamethasone (pulse) | Worsened rapidly the next day (hemiparesis MMT 3 ⇒ tetraparesis MMT 1) | Steroid discontinuation, shunt/feeder surgical occlusion | Recovery, MMT 1 ⇒ 4 |
| Case | 72/M | Craniocervical junction | Tetraparesis, sensory disturbance, urinary incontinence | Methylprednisolone (pulse) | Worsened rapidly on the same day | Steroid discontinuation, shunt/feeder surgical occlusion | Recovery, MMT 0 ⇒ 4 |
| No. | Age (years)/sex | Level | Symptoms | Steroids | Symptoms after steroid use | Treatments | Postop. course |
| Case 3 | 45/F | Conus (perimedullary) | Paraparesis, sensory disturbance, gait disturbance | Methylprednisolone (pulse) | Worsened rapidly on the same day | Steroid discontinuation, shunt/feeder surgical occlusion | Recovery, MMT 3 ⇒ 4 |
| Case 4 | 60/M | Conus (extradural) | Paraparesis, sensory disturbance, gait disturbance, bladder–rectal impairment | Methylprednisolone (pulse) | Worsened rapidly on the same day | Steroid discontinuation, transarterial embolization | Recovery in sensory, MMT 0 ⇒ 1, hypesthesia below Th10 ⇒ below L4 |
Postop.: postoperative, M: male, F: female, Rt.: right, MMT: manual muscle test, U/E: upper extremity.
Fig. 3(A) Intramedullary high-intensity lesion was found from thoracic to conus level on MRI T2WI. Abnormal flow voids were found around the cord. (B) Abnormal perimedullary vein was depicted with CT angiography. (C) Spinal AVF (epidural AVF) at Th7 was depicted with spinal DSA. 58-year-old man: He had a year history of bilateral foot paresthesia. Gait disturbance, mild urinary retention, and constipation occurred gradually. He visited the local clinic and suspected lumbar canal stenosis. The symptoms deteriorated with a few days course with the prescribed PGE1 agent. Spinal AVF was suspected on lumbar MRI, and he was referred to our service. AVF: arteriovenous fistula, CT: computed tomography, DSA: digital subtraction angiography, MRI: magnetic resonance imaging, PGE1: prostaglandin E1, T2WI: T2-weighted image.